Get the app!
Back to Trades

Hollander David

Chief R&D OfficerCIK 0001793796

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Hollander David, Chief R&D Officer, accounts for 2 disclosed filings worth $1.9M, all concentrated in Veradermics, Inc (MANE), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Sep 3MANE
Veradermics, Inc
Hollander DavidChief R&D OfficerGrant$1.9M
Aug 20MANE
Veradermics, Inc
Hollander DavidChief R&D OfficerOther$0

2 filings